Stocks
Axsome Therapeutics (AXSM) OCF US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| OCF, bln rub | ? | -78.5 | -108.2 | -116.5 | -145.1 | -132.6 | |||
| Changes by years, y/y, % | +69% | +38% | -100% | +25% | +37.0% | ||||
Axsome Therapeutics. OCF, bln rub
Axsome Therapeutics. OCF, changes, %
Axsome Therapeutics. OCF, sum by quarters, bln rub
Axsome Therapeutics (AXSM) OCF US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| OCF, bln rub | ? | -53.5 | -30.4 | -53.5 | -30.1 | -18.6 | -132.6 | |
| Changes by years, y/y, % | +135% | +10% | +819% | -46% | -65% | |||
| Changes by quarters, q/q, % | -3% | -43% | +76% | -44% | -38% | |||
